Tech Talent Tuesday - 1910 Genetics

This weekly blog from MCS shines a light on some of the most influential women working within the tech sphere. 

Fact: Only 2% of funding goes to women-led start-ups. For women of colour, the stats are far more dismal at just 0.64%.  

That’s why MCS is kicking off this series of blogs with Jen Nwankwo, the black-female Founder & CEO of 1910 Genetics. 

Jen attended Harvard Medical School where she conducted her Doctoral before going on to complete a PhD at Tufts University School of Medicine in Pharmacology & Experimental Therapeutics. With over ten years of experience working within the pharmaceutical and healthcare industry- to say she understands the pharmaceutical industry is an understatement! 

Jen doesn’t come from a tech background but became enthused with AI in 2016 whilst working on sickle cell drug discovery at a Boston hospital. She began thinking about how she could apply the technology to the problems she faced as a drug developer.  

Jen’s enthusiasm for AI, her industry knowledge, innovation and passion spurred her to found 1910 Genetics in 2017. The company has gone from strength to strength since it was founded securing a $4.1 seed led by a personal investment from Y Combinator and  Sam Altman, CEO of OpenAI. 

The company integrates Artificial intelligence, computation, and biological automation to accelerate the design of small molecule and protein therapeutics. This is an unmatched capability in the AI drug discovery space and has revolutionised drug discovery programs.  

This is only the beginning for this exciting start-up. To find out more about 1910 Genetics and  follow their journey, check them out on Linkedin at: https://www.linkedin.com/company/1910genetics/ 

Make sure you are following us to find out about more inspiring women in tech and to keep up to date with MCS